The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
Open accessAbstract
Respiratory viruses infect the human upper respiratory tract, mostly causing mild diseases. However, in vulnerable populations, such as newborns, infants, the elderly and immune-compromised individuals, these opportunistic pathogens can also affect the lower respiratory tract, causing a more severe disease (e.g., pneumonia). Respiratory viruses can also exacerbate asthma and lead to various types of respiratory distress syndromes. Furthermore, as they can adapt fast and cross the species barrier, some of these pathogens, like influenza A and SARS-CoV, have occasionally caused epidemics or pandemics, and were associated with more serious clinical diseases and even mortality. For a few decades now, data reported in the scientific literature has also demonstrated that several respiratory viruses have neuroinvasive capacities, since they can spread from the respiratory tract to the central nervous system (CNS). Viruses infecting human CNS cells could then cause different types of encephalopathy, including encephalitis, and long-term neurological diseases. Like other well-recognized neuroinvasive human viruses, respiratory viruses may damage the CNS as a result of misdirected host immune responses that could be associated with autoimmunity in susceptible individuals (virus-induced neuro-immunopathology) and/or viral replication, which directly causes damage to CNS cells (virus-induced neuropathology). The etiological agent of several neurological disorders remains unidentified. Opportunistic human respiratory pathogens could be associated with the triggering or the exacerbation of these disorders whose etiology remains poorly understood. Herein, we present a global portrait of some of the most prevalent or emerging human respiratory viruses that have been associated with possible pathogenic processes in CNS infection, with a special emphasis on human coronaviruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical, post-mortem, animal, in vitro, and cell culture studies demonstrated that coronaviruses are potentially neurotropic and can induce neuronal injuries (Desforges et al., 2019).”
From Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors (2020) · cites this paper as Desforges et al., 2019
In the citing paper
“As a consequence, CoV can enter the brain through the olfactory tract in the early stages of infection or nasal vaccination (Desforges et al., 2019, Mori, 2015).”
From Nervous system involvement after infection with COVID-19 and other coronaviruses (2020) · cites this paper as Desforges et al., 2019
In the citing paper
“Although there is rare evidence that CoV, especially SARS-CoV-2, invade the nervous system via the blood circulation pathway (Koyuncu et al., 2013, Desforges et al., 2019), subsequent studies are expected.”
From Nervous system involvement after infection with COVID-19 and other coronaviruses (2020) · cites this paper as Desforges et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Guan, Y., Zheng, B., He, Y., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S., Li, P. H., Zhang, L., Guan, Y., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,404
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 999
SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability
Casoli, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073782 · Cited by 10
Althenayan, A. S., Alsalamah, S., Aly, S. F., Nouh, T. A., & Mirza, A. A. (2022) · Applied Sciences · doi:10.3390/app122010535 · Cited by 11
Farrokhi, M. R., Iravanpour, F., & Nejabat, N. (2023) · European Neurology · doi:10.1159/000529927 · Cited by 10
Liu, C., Chiu, L., Lee, C.-C., & Chan, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1240089 · Cited by 10
Cavalcanti, I. D. L., Macêdo, D. C. D. S., Macêdo, D. C. D. S., Cavalcanti, I. M. F., & Nogueira, M. C. D. B. L. (2020) · Current Drug Delivery · doi:10.2174/1567201817666200827110445 · Cited by 10
The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment
Захаров, Д. В., & Buriak, I. V. (2021) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2021-57-4-97-105 · Cited by 10
Neto, J. X., Vieira, D. S., de Andrade, J., & Fulco, U. L. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01544 · Cited by 10
SARS-CoV-2 and Guillain–Barré Syndrome: Lessons from Viral Infections
Meidaninikjeh, S., Sabouni, N., Taheri, M., Borjkhani, M., Bengar, S., Zolbanin, N. M., Khalili, A., & Jafari, R. (2022) · Viral Immunology · doi:10.1089/vim.2021.0187 · Cited by 10
Cataldo, A., Criscuolo, S., Benedetto, E. D., Masciullo, A., Pesola, M., & Schiavoni, R. (2023) · Bioengineering · doi:10.3390/bioengineering10040435 · Cited by 10
Caronna, E., & Pozo‐Rosich, P. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14059 · Cited by 10
Zegarra-Valdivia, J. A., Vilca, B. N. C., Tairo-Cerrón, T., Munive, V., & Lastarria, C. P. (2020) · doi:10.31219/osf.io/2fqtz · Cited by 10
Dmitrova, E., Smiyan, O., Holubnycha, V., Smiian-Horbunova, K. O., Бында, Т. П., Reznychenko, Y., Vysotsky, I. Y., Vasylieva, O. H., Плахута, В. А., Manko, Y. A., et al. (2021) · Proceedings of the Shevchenko Scientific Society Medical Sciences · doi:10.25040/ntsh2021.02.17 · Cited by 9
Ma, W., Su, Y., Zhang, P., Wan, G., Cheng, X., Lu, C., & Gu, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1205541 · Cited by 9
COVID‐19 and Mental Health: A “Pandemic Within a Pandemic”
Fisicaro, F., Lanza, G., Concerto, C., Rodolico, A., Napoli, M. D., Mansueto, G., Cortese, K., Mogavero, M. P., Ferri, R., Bella, R., et al. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-61943-4_1 · Cited by 10
Martínez, A. J. G., Gálvez, M. A., Sanz, S. R., Ruiz, P. H., Morillas, A. G., & Sánchez, T. E. (2020) · Otolaryngologia Polska · doi:10.5604/01.3001.0014.3451 · Cited by 9
Characterization of Headache in COVID-19: a Retrospective Multicenter Study
de Paula, R. C. D. A., Vasconcelos, T. D. M. F., da Costa, F. B. S., de Brito, L. A., Torres, D., Moura, A. E. F., Oliveira, D. N., Henn, G. A. D. L., Rodrigues, P. G. B., Pereira, I. D. S., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02430-w · Cited by 9
Assessment of new-onset depression and anxiety associated with COVID-19
Hurissi, E., Abujabir, E. I. M., Mohammed, A., Mahnashi, M. S., Alharbi, S., Alharbi, A., Alnaami, A., Alameer, E., Alahmar, A. S., & Alhazmi, A. (2021) · Middle East Current Psychiatry · doi:10.1186/s43045-021-00112-w · Cited by 9
Central nervous system complications in SARS-CoV-2-infected patients
Li, Z., Lin, D., Xu, X., Liu, X., Zhang, J., Huang, K., Wang, F., Liu, J., Zhang, Z., & Tao, E. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11912-x · Cited by 9
Olfactory dysfunction as an indicator of early coronavirus infection
Bigday, E. V., & Samoilov, V. O. (2020) · Integrative Physiology · doi:10.33910/2687-1270-2020-1-3-187-195 · Cited by 9
Bromelain: A Review on its Potential as a Therapy for the Management of Covid-19.
Owoyele, B. V., Bakare, A. O., & Ologe, M. O. (2020) · PubMed · Cited by 9
Fragiel, M., Miró, Ò., Llorens, P., Jiménez, S., Piñera, P., Putze, G. B., Martı́n, A., Martín‐Sánchez, F. J., Lamberechts, E. J. G., Jacob, J., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04206-5 · Cited by 9
Secondary antiviral metabolites from fungi with special reference to coronaviruses
Salem, M. A., El‐Metwally, M. M., Saber, W. I. A., Negm, S., El-kott, A. F., MAZROUA, Y., Makhlouf, A. H., & Moustafa, M. (2022) · Biocell · doi:10.32604/biocell.2022.019301 · Cited by 9
Challenges and Implications of the COVID-19 Pandemic on Mental Health: A Systematic Review
Abubakar, A. R., Tor, M. A., Ogidigo, J. O., Sani, I. H., Rowaiye, A. B., Ramalan, M. A., Najib, Y. S., Danbala, A. A., Adamu, F., Abdullah, A., et al. (2022) · Psych · doi:10.3390/psych4030035 · Cited by 10
Lu, Z., Wang, Z., Song, Z., Chen, C., Ma, H., Gong, P., & Xu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.971017 · Cited by 9
Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
Borovčanin, M., Vesić, K., Balcıoğlu, Y. H., & Mijailović, N. R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1052710 · Cited by 9
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
Mirmosayyeb, O., Ghaffary, E. M., Dehghan, M. S., Ghoshouni, H., Bagherieh, S., Barzegar, M., & Shaygannejad, V. (2023) · Journal of Central Nervous System Disease · doi:10.1177/11795735231167869 · Cited by 9
Kolehmainen, P., Huttunen, M., Iakubovskaia, A., Maljanen, S., Tauriainen, S., Yatkin, E., Pasternack, A. H., Naves, R. A., Toivonen, L., Tähtinen, P. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35471-3 · Cited by 12
Montgomery, S., Vingeliene, S., Li, H., BACKMAN, H. E., Udumyan, R., Jendeberg, J., Rasmussen, G., Sundqvist, M., Fall, K., Hiyoshi, A., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae406 · Cited by 8
Unravelling the Viral Hypothesis of Schizophrenia: A Comprehensive Review of Mechanisms and Evidence
Sighencea, M. G., & Trifu, S. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157429 · Cited by 9
Remitting neuropsychiatric symptoms in COVID‐19 patients: Viral cause or drug effect?
Forero-Peña, D. A., Hernandez, M. M., Herrera, I. P. M., Espinal, I. B. C., Paz, J. P., Ferro, C., Flora‐Noda, D. M., Maricuto, A. L., Velásquez, V. L., Camejo‐Ávila, N. A., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27443 · Cited by 9
Elshebawy, H., Ezzeldin, M. Y., & Elzamarany, E. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00435-9 · Cited by 8
Ekusheva, E. V., Войтенков, В. Б., & Ризаханова, О. А. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112112133 · Cited by 8
Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review
Azhar, A., Wali, M. A., Rashid, Q., Khan, W. H., Alhosaini, K. A., Owais, M., & Kamal, M. A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220418114009 · Cited by 8
Patterns of COVID-19-related headache: A cross-sectional study
Şahin, B. E., Çelikbilek, A., Koçak, Y., & Hızmalı, L. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107339 · Cited by 8
Hsu, P.-C., & Shahed-Al-Mahmud, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120981 · Cited by 9
Luczo, J. M., Edwards, S. J., Ardipradja, K., Suen, W. W., Au, G. G., Marsh, G. A., Gödde, N., Rootes, C. L., Bingham, J., & Sundaramoorthy, V. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-023-01187-3 · Cited by 8
COVID-19 related neurological manifestations in Parkinson’s disease: has ferroptosis been a suspect?
Jia, F., & Han, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01915-6 · Cited by 9
Neurology and the COVID-19 Pandemic
High, B., Hixon, A. M., Tyler, K. L., Piquet, A. L., & Pelak, V. S. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000908 · Cited by 8
Xiao, T., Xia, S., Zeng, L., Lin, G. W., Wei, Q., Zhou, W., Zhuang, D., Chen, X., Yi, B., Li, L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038004 · Cited by 8
Chiesa-Estomba, C. M., Lechien, J. R., & Saussez, S. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.05.005 · Cited by 8
Monroy-Gómez, J. A., & Torres‐Fernández, O. (2020) · Biomédica · doi:10.7705/biomedica.5682 · Cited by 8
COVID-19 and manifest psychological morbidity
Kumar, P., Kamal, S., Tuli, S., & Gupta, N. (2021) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_152_21 · Cited by 8
Quarleri, J. F., & Delpino, M. V. (2022) · GeroScience · doi:10.1007/s11357-022-00528-0 · Cited by 9
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
Bartolomé, F. B., Rosa, L., Valenti, P., Lopera, F. J., Hernández‐Gallego, J., Cantero, J. L., Orive, G., & Carro, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878201 · Cited by 8
Baslet, G. C., Aybek, S., Ducharme, S., Modirrousta, M., & Nicholson, T. R. (2022) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.21080209 · Cited by 8
Association of compliance with COVID-19 public health measures with depression
Byun, J. A., Sim, T. J., Lim, T. Y., Jang, S., & Kim, S. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-17110-5 · Cited by 8
Omidian, N., Mohammadi, P., Sadeghalvad, M., & Mohammadi‐Motlagh, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113534 · Cited by 9
Kumar, C. S., Singh, B., Rizvi, Z. A., Parray, H. A., Verma, J. K., Ghosh, S., Mukhopadhyay, A., Awasthi, A., Shrivastava, T., & Banerjee, M. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00217 · Cited by 8
Normatov, M. G., Karev, V. E., Kolobov, A., Mayevskaya, V. A., Ryabkova, V. A., Utekhin, V. J., & Churilov, L. P. (2023) · Diagnostics · doi:10.3390/diagnostics13030522 · Cited by 8
Mazhari, S., Sabahi, A., Gilanipour, H., & Keshvardoost, S. (2022) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_1519_21 · Cited by 8
Beyond skin deep: shedding light on the neuropsychiatric consequences of Monkeypox (Mpox)
Nakhaie, M., Pirmoradi, Z., Bashash, D., Rukerd, M. R. Z., & Charostad, J. (2023) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02361-4 · Cited by 8
Neurological manifestations in COVID-19 and its possible mechanism
Tang, X., Luo, Y., Song, Y., Fan, H., Dong, S., Liu, P., & Chen, Y. (2020) · Aging · doi:10.18632/aging.103732 · Cited by 7
Akkaya, H., ̆lu, A. K., Dılek, O., ̆li, C. B., Kaya, Ö., Yılmaz, C., & Gülek, B. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20210678 · Cited by 8
Li, C., Burrell, R., Dale, R. C., Kesson, A. M., Blyth, C. C., Clark, J. E., Crawford, N. W., Jones, C., Britton, P. N., & Holmes, E. C. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001736 · Cited by 8
Chen, C., Ning, X., Fang, Y., Huang, Q., Li, X., Luo, Y., & Huang, Q. M. (2020) · doi:10.21203/rs.3.rs-22061/v1 · Cited by 8
Spectrum of Neurological Manifestations in COVID-19: A Review
Quraishi, F. A., Rahman, A., & Twinkle, F. Q. (2021) · Bangladesh Journal of Medicine · doi:10.3329/bjm.v32i2.53790 · Cited by 7
Smail, S. W., Babaei, E., & Amin, K. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0082 · Cited by 7
Cognitive deficits and cortical volume loss in COVID ‐19‐related hyposmia
Gezegen, H., Ay, U., Samancı, B., Kurt, E., Oner, S. S. Y., Medetalibeyoğlu, A., Şen, C., Şahin, E., Barbüroğlu, M., Doğan, F. U., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16378 · Cited by 9
Metabolic changes assessed by 1H MR spectroscopy in the corpus callosum of post-COVID patients
Pajuelo, D., Dezortová, M., Hájek, M., Ibrahimová, M., & Ibrahim, I. (2024) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-024-01171-w · Cited by 7
Pacnejer, A.-M., Butucă, A., Dobrea, C. M., Arseniu, A. M., Frum, A., Gligor, F. G., Arseniu, R., Vonica, R. C., Vonica-Țincu, A. L., Oancea, C. I., et al. (2024) · Viruses · doi:10.3390/v16121811 · Cited by 8
He, G., Sun, Z., Zhao, Y., Zhang, S., Chen, H., Zhao, Z., Yang, G., & Zhou, Q. (2020) · PubMed Central · Cited by 7
Paez, Y. M., Bennett, J. L., Subramanian, P. S., & Pelak, V. S. (2020) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001016 · Cited by 7
El‐Fakharany, E. M., El‐Maradny, Y. A., Othman, A. M., Gerges, M., Belal, F., & Behery, E. (2020) · Microbial Biosystems · doi:10.21608/mb.2020.33405.1018 · Cited by 7
Hussain, M. E., Hoque, M. A., Alam, M. B., Yusuf, M. A., Chowdhury, R. N., & Mohammad, Q. D. (2020) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v38i0.47869 · Cited by 7
Back to the future: lessons from past viral infections and the link with Parkinson’s disease
Dowd, E., & McKernan, D. P. (2021) · Neuronal Signaling · doi:10.1042/ns20200051 · Cited by 7
Neurological manifestations in COVID-19: an overview
Afshar, Z. M., Babazadeh, A., Khatir, A. A., Mohammadnia‐Afrouzi, M., Javanian, M., Vasigala, V. R., Hosseinnia, H., & Ebrahimpour, S. (2021) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.20.01895-7 · Cited by 7
Dadkhah, M., Talei, S., Doostkamel, D., Molaei, S., & Rezaei, N. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0154 · Cited by 7
Neurological manifestations in mild and moderate cases of COVID-19
Azim, G. S. A., & Osman, M. A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00363-8 · Cited by 8
Razi, O., Teixeira, A. M., Tartibian, B., Zamani, N., & Knechtle, B. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04610-1 · Cited by 8
A study of hematological parameters in patients with COVID-19 infection at a tertiary care centre
Patel, K. A., Patel, B., Parmar, R. A., Sharma, B. S., Thacker, M., & Patel, N. (2021) · Journal of Pathology of Nepal · doi:10.3126/jpn.v11i1.31401 · Cited by 7
Severe acute respiratory syndrome (SARS)
Beltz, L. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98809-4.00004-8 · Cited by 7
Sha, A., & Chen, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1169740 · Cited by 7
Juby, A. G., Cunnane, S. C., & Mager, D. R. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1126534 · Cited by 8
Mendoza, J. L., Estrada, V. H. N., López, N. B., Bolaños, E. R., Franco, D. M., Castell, C. R. D., Moreno, A. A. V., Amaya, I., Flórez, J. S., VALENCIA, B. A. G., et al. (2020) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2020.09.004 · Cited by 8
Understanding the neurological implications of acute and long COVID using brain organoids
García‐González, L., Martí-Sarrias, A., Puertas, M. C., Bayón-Gil, Á., Resa‐Infante, P., Martínez‐Picado, J., Navarro, A., & Acosta, S. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050049 · Cited by 7
Beeg, M., Baroni, S., Piotti, A., Porta, A., Luigi, A. D., Cagnotto, A., Gobbi, M., Diomede, L., & Salmona, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512146 · Cited by 6
COVID-19 and Comorbidities: What Has Been Unveiled by Metabolomics?
Camelo, A. L. M., Zamora-Obando, H. R., Rocha, I., Dias, A. C., Mesquita, A. D. S., & Simionato, A. V. C. (2024) · Metabolites · doi:10.3390/metabo14040195 · Cited by 7
Frontiers and hotspots in anxiety disorders: A bibliometric analysis from 2004 to 2024
Liu, G.-Y., Yan, M.-D., Mai, Y.-Y., Fu, F.-J., Pan, L., Zhu, J.-M., Ji, W.-J., Hu, J., Li, W., & Xie, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35701 · Cited by 10
Gavrilova, N. Y., Normatov, M. G., Сопрун, Л. А., Utekhin, V. J., Fedotkina, T. V., & Churilov, L. P. (2024) · Current Microbiology · doi:10.1007/s00284-024-03885-5 · Cited by 6
Gupte, A., Sriram, S., Gunasekaran, V., Chaudhari, K., & Kamat, D. (2025) · Pediatric Annals · doi:10.3928/19382359-20241106-01 · Cited by 6
Chen, Z., Wang, X., & Huang, W. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01536-7 · Cited by 6
Meyer, P., & Zaiser, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-04166-2 · Cited by 7
COVID-19 – prime time for microphysiological systems, as illustrated for the brain
Kang, I. (2021) · ALTEX · doi:10.14573/altex.2110131 · Cited by 6
Reeves, R. R., & Willoughby, S. G. (2022) · Journal of Osteopathic Medicine · doi:10.1515/jom-2021-0195 · Cited by 6
Akıncı, T. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-02980-5 · Cited by 6
Zhang, R., Wang, Q., & Yang, J. (2022) · Medicine · doi:10.1097/md.0000000000029164 · Cited by 6
Higazy, D., Lin, X., Xie, T., Wang, K., Gao, X., & Cui, M. (2022) · Animal Diseases · doi:10.1186/s44149-022-00053-9 · Cited by 6
Neurotropic SARS-CoV-2: Causalities and Realities
Pardasani, M., & Abraham, N. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108573 · Cited by 5
Erlangsen, A., Qin, P., Madsen, T., Hawton, K. E., Osler, M., Hjorthøj, C. R., Benros, M. E., Ethelberg, S., Mølbak, K., Laursen, T. M., et al. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.194 · Cited by 6
Invitto, S., Boscolo‐Rizzo, P., Fantin, F., Bonifati, D. M., de Filippis, C., Emanuelli, E., Frezza, D., Giopato, F., Caggiula, M., Schito, A., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10030376 · Cited by 6
Liu, H., Lü, R., Yang, J., Xiang, M., Ban, D., Yang, J.-W., Guo, Z.-H., Yuan, T.-Y., & Fu, H.-M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1223521 · Cited by 6
Rakhshani, T., Nikeghbal, S., Kashfi, S. M., Kamyab, A., Harsini, P. A., & Jeihooni, A. K. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1326760 · Cited by 6
Bilateral paresthesia associated with cardiovascular disease and COVID‐19
Moreira, M. S., Neves, I. L. I., Bernoche, C., Sarra, G., dos Santos‐Paul, M. A., da Silva, F. C. N., Schröter, G. T., Montano, T. C. P., de Carvalho, C. M. A., & Neves, R. S. (2020) · Oral Diseases · doi:10.1111/odi.13539 · Cited by 6
Affes, Z., Bouvard, E., Lévy, P., Dussaule, C., Grateau, G., & Haymann, J. (2020) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000795 · Cited by 6
Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series
Tutar, N. K., Ömerhoca, S., Coban, E., & Kale, N. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102900 · Cited by 6
Vertebral Pain in Acute COVID-19—Cases Report
Chochol, J., Džubera, A., Illéš, R., Chocholová, A., & Zemková, E. (2021) · Applied Sciences · doi:10.3390/app11156926 · Cited by 6
Onaolapo, A. Y., & Onaolapo, O. J. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666211222162811 · Cited by 6
Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19
Razi, O., Tartibian, B., Laher, I., Govindasamy, K., Zamani, N., Rocha‐Rodrigues, S., Suzuki, K., & Zouhal, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.783251 · Cited by 6
Du, Y., Zhao, W., Lei, D., & Liu, J. (2021) · Psychoradiology · doi:10.1093/psyrad/kkab019 · Cited by 6
Carmassi, C., Sampogna, G., Vincenzo, M. D., Cipolla, S., Toni, C., Albert, U., Carrà, G., Cirulli, F., Dell’Osso, B. M., Fantasia, S., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3314 · Cited by 6
Metadata
- Authors
- Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J.
- Affiliations
- Institut National de la Recherche Scientifique (CA)
- Laboratory of Neuroimmunovirology, Institut national de la recherche scientifique (INRS)-Institut Armand-Frappier, Université du Québec, Laval, QC H7V 1B7, Canada
- Université de Sherbrooke (CA)
- Corresponding author
- Desforges, Marc
- Talbot, Pierre J.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2019-12-20
- Volume
- 12
- Issue
- 1
- Pages
- 14
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC7020001
- OpenAlex
- W2995936855
- Cited by
- 1,048
- References
- 341
- Citations by year
- 2026: 16 · 2025: 32 · 2024: 59 · 2023: 101 · 2022: 200 · 2021: 323 · 2020: 314 · 2019: 3
- FWCI
- 29.51
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EspaceINRS (National Institute for Scientific Research (Canada)) (submittedVersion)
- HAL (submittedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Funders
- Canadian Institutes of Health Research (MT-9203)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- human coronaviruses, respiratory viruses, central nervous system infection, encephalitis, neuropathology, opportunistic pathogens, emerging respiratory viruses, influenza A virus, SARS-CoV, autoimmunity, neurological disorders
- MeSH terms
- Animals, Central Nervous System, Humans, Nervous System Diseases, Respiratory Tract Infections, Virus Replication, Coronavirus, Coronavirus Infections, Encephalitis, Viral, Central Nervous System Viral Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
